ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses

Yu, Hao; Li, Xing-Xiu; Han, Xing; Chen, Bin-Xin; Zhang, Xing-Hua; Gao, Shan; Xu, Dan-Qi; Wang, Yao; Gao, Zhan-Kui; Yu, Lei; Zhu, Song-Ling; Yao, Li-Chen; Liu, Gui-Rong*; Liu, Shu-Lin*; Mu, Xiao-Qin*哈尔滨医科大学
Frontiers in Microbiology2023-4-18DOI: 10.3389/fmicb.2023.1126808
9被引12閱讀
引用收藏
分享

摘要

Many lines of evidence demonstrate the associations of colorectal cancer (CRC) with intestinal microbial dysbiosis. Recent reports have suggested that maintaining the homeostasis of microbiota and host might be beneficial to CRC patients, but the underlying mechanisms remain unclear. In this study, we established a CRC mouse model of microbial dysbiosis and evaluated the effects of fecal microbiota transplantation (FMT) on CRC progression. Azomethane and dextran sodium sulfate were used to induce CRC and microbial dysbiosis in mice. Intestinal microbes from healthy mice were transferred to CRC mice by enema. The vastly disordered gut microbiota of CRC mice was largely reversed by FMT. Intestinal microbiota from normal mice effectively suppressed cancer progression as assessed by measuring the diameter and number of cancerous foci and significantly prolonged survival of the CRC mice. In the intestine of mice that had received FMT, there were massive infiltration of immune cells, including CD8(+) T and CD49b(+) NK, which is able to directly kill cancer cells. Moreover, the accumulation of immunosuppressive cells, Foxp3(+) Treg cells, seen in the CRC mice was much reduced after FMT. Additionally, FMT regulated the expressions of inflammatory cytokines in CRC mice, including down-regulation of IL1a, IL6, IL12a, IL12b, IL17a, and elevation of IL10. These cytokines were positively correlated with Azospirillum_sp._47_25, Clostridium_sensu_stricto_1, the E. coli complex, Akkermansia, Turicibacter, and negatively correlated with Muribaculum, Anaeroplasma, Candidatus_Arthromitus, and Candidatus Saccharimonas. Furthermore, the repressed expressions of TGFb, STAT3 and elevated expressions of TNFa, IFNg, CXCR4 together promoted the anti-cancer efficacy. Their expressions were positively correlated with Odoribacter, Lachnospiraceae-UCG-006, Desulfovibrio, and negatively correlated with Alloprevotella, Ruminococcaceae UCG-014, Ruminiclostridium, Prevotellaceae UCG-001 and Oscillibacter. Our studies indicate that FMT inhibits the development of CRC by reversing gut microbial disorder, ameliorating excessive intestinal inflammation and cooperating with anti-cancer immune responses.

學科與關鍵詞

關鍵詞
colorectal cancerintestinal microbiotafecal microbiota transplantationinflammationanti-cancer immune responses
相關
載入中…
  • Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment
    Xia, Cong; Cai, Yantao; Ren, Shuangyi*; Xia, Chenglai*Frontiers in Pharmacology, 2022, 13: 1051330.被引 4
  • Gut microbiome in tumorigenesis and therapy of colorectal cancer
    Wang, Ling; Yu, Ke-Chun; Hou, Yun-qing; Guo, Min; Yao, Fan; Chen, Zhen-Xia*Journal of Cellular Physiology, 2023, 238(1): 94-108.被引 4
  • Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
    Ou, Suwen; Wang, Hufei; Tao, Yangbao; Luo, Kangjia; Ye, Jinhua; Ran, Songlin; Guan, Zilong; Wang, Yuliuming; Hu, Hanqing; Huang, Rui*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1020583.被引 10
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Frontiers in Microbiology
發表日期
2023-04-18
卷期
第 14 卷
頁碼
1126808
DOI
10.3389/fmicb.2023.1126808
語言
ENGLISH
成果收錄
SCIE
資助標註
National Natural Science Foundation of China [NSFC81903631, NSFC81971910, NSFC81871623, NSFC82020108022]; Youth Innovation Fund of University [UNPYSCT-2018065]; Postdoctoral Research Startup Fund of Heilongjiang Province [LBH-Q15080]

作者

  • Y

    Yu, Hao (第一作者)

    harbin med univ

  • L

    Li, Xing-Xiu

    harbin med univ

查看全部 15 位作者收起作者
  • H

    Han, Xing

    harbin med univ

  • C

    Chen, Bin-Xin

    harbin med univ

  • Z

    Zhang, Xing-Hua

    harbin med univ

  • G

    Gao, Shan

    2 · harbin med univ

  • X

    Xu, Dan-Qi

    harbin med univ

  • W

    Wang, Yao

    harbin med univ

  • G

    Gao, Zhan-Kui

    harbin med univ

  • Y

    Yu, Lei

    2 · harbin med univ

  • Z

    Zhu, Song-Ling

    harbin med univ

  • Y

    Yao, Li-Chen

    harbin med univ

  • L

    Liu, Gui-Rong (通訊)

    harbin med univ

  • L

    Liu, Shu-Lin (通訊)

    harbin med univ

  • M

    Mu, Xiao-Qin (通訊)

    harbin med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417